Strategies to Improve Compliance with Narcotic Antagonists

References

• Wilder A. The theoretical basis of narcotic addiction treatment with naicotic antagonists. Narcotic Antagonists: Naltrexone, D. Julius, P. Renault. NIDA Research. 1976; 119–122, Monograph 9
   Google Scholar
• Kleber H. D. Clinical experiences with narcotic antagonists. Opiate Addiction: Origins and Treatment, S. Fisher, A. M. Freedman. Winston, New York 1973; 211–220
   Google Scholar
• Pierson P. S., Rapfein R. M., Kleber H. D. Naloxone in the treatment of the young heroin abuser. Am. J. Drug Alcohol Abuse 1974; 1: 243–252
   PubMed Web of Science ®Google Scholar
• Kleber H. D., et al. The use of cyclazocine in treating narcotic addicts in a low intervention setting. Arch. Gen. Psychiatry 1974; 30: 37–42
   PubMed Web of Science ®Google Scholar
• Bradford H. A., Hurley F. L., Golondyzowski O., Dorrier C. Interim report on clinic intake and safety data collected from 17 NIDA funded naltrexone studies. Narcotic Antagonists: Naltrexone, D. Julius, P. Renault. NIDA Research. 1976; 163–171, Monograph 9
   Google Scholar
• Martin W. R., Jasinski D., Mansky P. Naltrexone, an antagonist for the treatment of heroin dependence. Arch. Gen. Psychiatry 1973; 23: 784–789
   Google Scholar
• Callahan E. J., . Comparison of two naltrexone treatment programs: Naltrexone alone versus naltrexone plus behavior therapy. Narcotic Antagonists: Naltrexone, D. Julius, P. Renault, et al. NIDA Research. 1976; 150–157, Monograph 9
   Google Scholar
• Resnick R. B., Washton A. M., Stone-Washton N., Rawson R. A. Psychotherapy and Naltrexone in Opioid Dependence. Paper presented at Committee on Problems of Drug Dependence. 1980
   Google Scholar
• Senay E. C. Detoxification of heroin addicts. J. Am. Med. Assoc. 1975; 233: 356–359
   Web of Science ®Google Scholar
• Kleber H. D. Detoxification from narcotics. Substance Abuse: Clinical Problems and Perspectives, J. H. Lowinson, P. Ruiz. Williams and Wilkins, Baltimore 1981; 317–338
   Google Scholar
• Gold M. S., Redmond D. E., Jr., Kleber H. D. Clonidine blocks acute opiate withdrawal symptoms. Lancet 1978; 2: 599–602
   PubMed Web of Science ®Google Scholar
• Uhde T. W., Redmond D. E., Jr., Kleber H. D. Clonidine suppresses the opioid abstinence syndrome without clonidine-withdrawal symptoms: A blind inpatient study. Psychiatr. Res. 1980; 2: 37–47
   PubMed Web of Science ®Google Scholar
• Gold M. S., et al. Opiate withdrawal using clonidine. J. Am. Med. Assoc. 1980; 243: 343–346
   PubMed Web of Science ®Google Scholar
• Washton A. M., Resnick R. B. Clonidine for opiate detoxification: Outpatient clinical trial. Am. J. Psychiatry 1980; 137: 1121–1122
   PubMed Web of Science ®Google Scholar
• Charney D. S., et al. The clinical use of clonidine in abrupt withdrawal from methadone. Arch. Gen. Psychiatry 1981; 38: 1273–1277
   PubMed Web of Science ®Google Scholar
• Washton A. M., Resnick R. B. Clonidine vs methadone for opiate detoxification: Double blind outpatient trials. Problems of Drug Dependence NIDA Research Monograph 34, L. S. Harris, 1981; 89–94
   Google Scholar
• Hollister L. E., Johnson K., Boukhabya D., Gillespie H. K. Aversive effects of naltrexone in subjects not dependent on opiates. Drug Alcohol Depend 1981; 8: 37–41
   PubMed Web of Science ®Google Scholar
• Simon E. J. Recent developments in the biology of opiates: Possible relevance to addiction. Substance Abuse: Clinical Problems and Perspectives, J. H. Lowinson, P. Ruiz. Williams and Wilkins, Baltimore 1981; 45–56
   Google Scholar
• Sideroff S. I., Charuwastra V. C, Jarvik M. E., Ouren J. Craving in heroin addicts maintained on the opiate antagonist naltrexone. Am. J. Drug. Alcohol Abuse 1978; 5(4)415–423
   PubMed Web of Science ®Google Scholar
• Kleber H. D., Gold M. D. Use of psychotropic drugs in treatment of methadone maintained narcotic addicts. Ann. N.Y. Acad. Sci. 1978; 311: 81–98
   PubMedGoogle Scholar
• Mirin S. M., Meyer R. E., McNamee H. B. Psychopathology and mood during heroin use: Acute vs chronic effects. Arch. Gen. Psychiatry 1976; 33: 1503–1508
   PubMed Web of Science ®Google Scholar
• Stanton M. D., et al. Heroin addiction as a family phenomenon: A new conceptual model. Am. J. Drug Alcohol Abuse 1978; 5(2)125–150
   PubMed Web of Science ®Google Scholar
• Kosten T. R., Jalali B. J., Kleber H. D. Complementary marital roles in male heroin addicts: Evolution and intervention tactics. Am. J. Drug Alcohol Abuse 1982–83; 9(2)155–169
   PubMed Web of Science ®Google Scholar
• Berenson D. Alcohol and the family system. Family Therapy: Theory and Practice, P. J. Guerin. Gardner, New York 1976
   Google Scholar
• Goldstein A. Are opiate tolerance and dependence reversible? Implications for the treatment of heroin addiction. Proc. Int. Symposia on Alcohol Drug Research, H. Cappell, A. E. LeBlanc. Toronto, Canada 1973; 27–41
   Google Scholar
• Callahan E. J., et al. The treatment of heroin addiction: Naltrexone alone with behavior therapy. Am. J. Drug Alcohol Abuse 1980; 7: 795–807
   Google Scholar
• Meyer R. E., Mirin S. M., Altman J. L., McNamer B. A behavioral paradigm for the evaluation of narcotic antagonists. Arch. Gen. Psychiatry 1976; 33: 371–377
   PubMed Web of Science ®Google Scholar
• Meyer R. E., Mirin S. M., Zackow F. Community outcome on narcotic antagonists. Tlie Heroin Stimulus, R. E. Meyer, S. M. Mirin. Plenum, New York 1979; 215–230
   Google Scholar
• Grabowski J., et al. Effects of contingent payment on compliance with a naltrexone regimen. Am. J. Drug Alcohol Abuse 1979; 6(3)355–365
   PubMed Web of Science ®Google Scholar
• Judson B. A., Goldstein A. Rapid induction to stable dosages of levomethadyl acetate (LAAM). Drug Alcohol Depend 1979; 4: 461
   PubMed Web of Science ®Google Scholar
• Anton R. F., Hogan I., Jalali B., Riordan C. E., Kleber H. D. Multiple family therapy and naltrexone in the treatment of opiate dependence. Drug Alcohol Depend 1981; 8: 157–168
   PubMed Web of Science ®Google Scholar
• Kleber H. D. Clinical aspects of the use of narcotic antagonists: The state of the art. Int. J. Addict. 1977; 12(7)857–861
   PubMed Web of Science ®Google Scholar
• Riordan C. E., Kleber H. D. Rapid opiate detoxification with clonidine and naloxone. Lancet May 17, 1980
   PubMed Web of Science ®Google Scholar
• Brownell K. D., Stunkard A. J. Couples training, pharmacotherapy, and behavior therapy in the treatment of obesity. Arch. Gen. Psychiatry 1981; 38: 1224–1229
   PubMed Web of Science ®Google Scholar
• Greenstein R. A., et al. Naltrexone: A short term treatment for opiate dependence. Am. J. Drug Alcohol Abuse 1981; 8(3)291–300
   PubMed Web of Science ®Google Scholar
• Kleber H. D. Methadone maintenance treatment-A reply. Am. J. Drug Alcohol Abuse 1977; 4(2)267–272
   PubMed Web of Science ®Google Scholar
• Vaillant E.-G. A 12 year follow-up of New York narcotic addicts 1: The relation of treatment to outcome. Am. J. Psychiatry 1966; 122: 727–737
   PubMed Web of Science ®Google Scholar
• Schecter A. The role of narcotic antagonists in the rehabilitation of opiate addicts: A review of naltrexone. Am. J. Drug Alcohol Abuse 1980; 7(1)1–18
   PubMed Web of Science ®Google Scholar
• Childers S. R., Simanto R., Synder S. H. Enkephalin: Radioimmunoassay and radioreceptor assay in morphine dependent rats. Eur. J. Pharmacol. 1977; 46: 289–297
   PubMed Web of Science ®Google Scholar
• Simantov R., Synder S. H. Elevated levels of enkephalin in morphine-dependent rats. Nature 1976; 262: 505–506
   PubMed Web of Science ®Google Scholar
• Su C. Y., et al. Effects of Bendorphin on narcotic abstinence syndrome in man. J. Formosan Med. Assoc. 1978; 77: 133
   Google Scholar
• Dole V. P., Nyswander M. E. A medical treatment for diacetylmorphine (heroin) addiction. J. Am. Med. Assoc. 1965; 193: 646–650
   PubMed Web of Science ®Google Scholar
• Riordan C. E., Kleber H. D. Rapid opiate detoxification with clinidine and naloxone. Lancet 1980; 1: 1079–1080
   PubMed Web of Science ®Google Scholar
• Charney D. S., et al. Clonidine and naltrexone. Arch. Gen. Psychiatry 1982; 39: 1327–1332
   PubMed Web of Science ®Google Scholar
• Jasinski D. R., Pevnick J. S., Griffith J. D. Human pharmacology and abuse potential of the analgesic buprenorphine: A potential agent for treating narcotic addiction. Arch. Gen. Psychiatry 1978; 35: 501–516
   PubMed Web of Science ®Google Scholar
• Jasinski D. R., . Progress report of the NIDA addiction research center. Problems of Drug Dependence, L. S. Harris, et al. NIDA Research. 1982; 45–52, Monograph 41
   Google Scholar
• O'Brien C. P., et al. Systematic extinction of narxotic use using narcotics antagonists. Psychosom. Med. 1974; 36: 458465
   Web of Science ®Google Scholar
• O'Brien C. P., Greenstein R. A. Treatment approaches: Opiate antagonists. Substance Abuse: Clinical Problems and Perspectives, J. H. Lowinson, P. Ruiz. Williams and Wilkins, Baltimore 1981; 403–407
   Google Scholar
• Solomon R. L., Corbit J. D. An opponent process theory of motivation: I. Temporal dynamics of affect. Psychol. Rev. 1974; 81: 119–145
   PubMed Web of Science ®Google Scholar
• Rounsaville B. J., Weissman M. M., Wilber C. H., Kleber H. D. The heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch. Gen. Psychiatry 1981; 39: 161–166
   Web of Science ®Google Scholar
• Kosten T. R., Rounsaville B. J., Kleber H. D. DSM-III personality disorders in opiate addicts. Compr. Psychiatry 1982; 23: 592–581
   Web of Science ®Google Scholar
• Spencley J. Doxepin A useful adjunct in the treatment of heroin addicts in a methadone program. Int. J. Addict. 1976; 11: 191–203
   PubMedGoogle Scholar
• Kleber H. D., Weissman M. M., RounsaviUe B. J., Wilber C. H., Prusoff B. A., Riordan C. E. Imipramine as treatment for depression in addicts. Arch. Gen. Psychiatry, in press
   Web of Science ®Google Scholar
• Woody G. E., O'Brien C. P., Rickels K. Depression and anxiety in heroin addicts: A placebo controlled study of doxepin in combination with methadone. Am. J. Psychiatry 1975; 132: 447–451
   PubMed Web of Science ®Google Scholar
• Alexander B. K., Coambs R. B., Hadaway P. F. The effect of housing and gender on morphine self-administration in rats. Psychopharmacology 1978; 58: 175–179
   PubMed Web of Science ®Google Scholar
• Robins L. N., Helzer J. E., Davis D. H. Narcotic use in Southeast Asia and afterwards. Arch. Gen. Psychiatry 1975; 32: 955–961
   PubMed Web of Science ®Google Scholar
• Maddux J. F., Desmond D. P. Residence relocation inhibits opioid dependence. Arch. Gen. Psychiatry 1982; 39: 1313–1317
   PubMed Web of Science ®Google Scholar
• Meyer R. E., Mirin S. M. The Heroin Stimulus: Implication for a Theory of Addiction. Plenum, New York 1982
   Google Scholar
• Cheek F. E. Broad spectrum behavioral training in self-control for drug addicts. Behay. Ther. 1972; 3: 515–528
   Web of Science ®Google Scholar
• RounsaviUe B. J., et al. Predictors of outcomes in treatment of opiate addicts-Evidence for the multidimensional nature of addicts' problems. Compr. Psychiatry, in press
   Google Scholar
• Kosten T. R., RounsaviUe B. J., Kleber H. D. Relationship of depression to psychosocial stressors in heroin addicts. J. Nerv. McNt. Dis. 1983; 171: 97–104
   PubMed Web of Science ®Google Scholar